About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT06505746

A Study of Real-world Treatment of Adults With Urothelial Cancer in South Korea and Saudi Arabia

Cancer in the bladder lining (urothelial cancer) can be treated in many ways. One way is to directly attack cancer cells. Enfortumab vedotin is a treatment that can do this. Another way is to help the...

Lead sponsor: Astellas Pharma Singapore Pte. Ltd.•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Astellas Pharma Singapore Pte. Ltd.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Physician sample:
•Medical oncologist or urologist (Medical oncologists only in Saudi Arabia. A minimum of 15 medical oncologists in South Korea, increased where possible, with the remaining sample consisting of urologists)
•Personally responsible for treatment and management of LA/mUC patients
•At least 50 percent of time spent in management of patients
•See a minimum of 4 LA/mUC patients per month
•Accept all survey rules and requirements
•Patient sample:
•Confirmed/physician assessed diagnosis of LA/mUC
•Patient is not currently enrolled in a clinical trial

Exclusion Criteria

•Patients currently enrolled in a clinical trial
•Patients participating in, or who have previously participated, in a clinical trial

Related studies

Active Not RecruitingPhase 1/2

Study of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors

NCT05101096 · Advanced Solid Tumor, Metastatic Triple-Negative Breast Cancer, and more

COMPLETEDPhase 1

A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4

NCT02091999 · Metastatic Urothelial Cancer and Other Malignant Solid Tumors

WITHDRAWNPhase 1/2

A Study of MFA-370 in Patients with Metastatic Urothelial Cancer

NCT05390645 · Metastatic Urothelial Cancer

COMPLETEDPhase 2

Gemcitabine + Carboplatin + Nivolumab Versus Gemcitabine + Oxaliplatin + Nivolumab in Cisplatin-ineligible Patients With Metastatic Urothelial Cancer

NCT03451331 · Metastatic Urothelial Cancer

COMPLETEDPhase 2

A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203)

NCT03679767 · Metastatic Non-small Cell Lung Cancer, Locally Advanced Urothelial Cancer, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 24, 2025Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment287

Start dateAug 2024

Last updatedMar 24, 2025

Condition

Metastatic Urothelial Cancer

Locations shown

KR00001

Seoul

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 24, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions